首页 > 最新文献

Orthopedic Reviews最新文献

英文 中文
Early Functional and Radiographic Outcomes of Stable Fixation with a Derotational Plate in Subtrochanteric Osteotomy for Crowe IV Developmental Dysplasia of the Hip. 旋转钢板稳定固定转子下截骨治疗Crowe IV型发育性髋关节发育不良的早期功能和影像学结果。
IF 2.1 Q3 ORTHOPEDICS Pub Date : 2025-12-22 eCollection Date: 2025-01-01 DOI: 10.52965/001c.150316
Zhanatay Ramazanov, Kairat Ashimov, Durdana Oktyabrova, Berk Guclu, Yerzhan Iskakov, Timur Baidalin, Bekzhan Suleimenov, Daniyar Yestay, Askarjan Beknazarov

Background: Developmental dysplasia of the hip (DDH) Crowe type IV poses significant surgical challenges during total hip arthroplasty (THA), often necessitating subtrochanteric shortening osteotomy (SSO) to achieve proper reduction and limb length restoration. Stable fixation of the osteotomy site is crucial for achieving reliable union and favorable functional outcomes.

Objective: To evaluate early clinical and radiographic outcomes of stable fixation using a derotational plate in subtrochanteric osteotomy for Crowe IV DDH.

Methods: A prospective cohort study was conducted on 28 patients (30 hips) with Crowe IV DDH who underwent THA combined with subtrochanteric osteotomy stabilized by a derotational plate. Clinical evaluation included the Harris Hip Score (HHS), Oxford Hip Score (OHS), and Visual Analogue Scale (VAS) for pain, assessed preoperatively and at 12 months postoperatively. Radiographic analysis focused on osteotomy union, implant stability, and restoration of limb length.

Results: All patients achieved union at the osteotomy site within 6 months, with no cases of nonunion or implant failure. Mean HHS improved from 38.5 ± 6.2 preoperatively to 89.7 ± 4.3 postoperatively (p < 0.001). Mean OHS increased from 17.4 ± 3.1 to 41.2 ± 2.8 (p < 0.001). VAS scores significantly decreased from 7.8 ± 1.0 to 1.6 ± 0.7 (p < 0.001). Complications were minimal, with one intraoperative femoral fissure (3.3%).

Conclusion: Stable fixation with a derotational plate in subtrochanteric osteotomy for Crowe IV DDH provides reliable union, excellent early functional recovery, and significant pain reduction at 12 months. These findings support its clinical effectiveness as a fixation method in complex THA cases.

背景:发育性髋关节发育不良(DDH) Crowe IV型在全髋关节置换术(THA)中提出了重大的手术挑战,通常需要转子下缩短截骨术(SSO)来实现适当的复位和肢体长度恢复。截骨部位的稳定固定对于实现可靠的愈合和良好的功能预后至关重要。目的:评价旋转钢板在Crowe IV DDH转子下截骨术中稳定固定的早期临床和影像学结果。方法:一项前瞻性队列研究对28例(30髋)Crowe IV DDH患者进行了THA联合转子下截骨术(旋转钢板稳定)。临床评估包括Harris髋关节评分(HHS)、Oxford髋关节评分(OHS)和视觉模拟疼痛评分(VAS),术前和术后12个月评估。放射学分析的重点是截骨愈合、植入物稳定性和肢体长度恢复。结果:所有患者均在6个月内在截骨部位愈合,无骨不连或种植体失败病例。平均HHS由术前38.5±6.2改善至术后89.7±4.3 (p < 0.001)。平均OHS由17.4±3.1增加到41.2±2.8 (p < 0.001)。VAS评分由7.8±1.0降至1.6±0.7,差异有统计学意义(p < 0.001)。并发症极少,术中出现1例股裂(3.3%)。结论:旋转钢板在Crowe IV DDH转子下截骨术中的稳定固定提供了可靠的愈合,良好的早期功能恢复,并在12个月时显著减轻疼痛。这些发现支持其作为复杂THA病例固定方法的临床有效性。
{"title":"Early Functional and Radiographic Outcomes of Stable Fixation with a Derotational Plate in Subtrochanteric Osteotomy for Crowe IV Developmental Dysplasia of the Hip.","authors":"Zhanatay Ramazanov, Kairat Ashimov, Durdana Oktyabrova, Berk Guclu, Yerzhan Iskakov, Timur Baidalin, Bekzhan Suleimenov, Daniyar Yestay, Askarjan Beknazarov","doi":"10.52965/001c.150316","DOIUrl":"10.52965/001c.150316","url":null,"abstract":"<p><strong>Background: </strong>Developmental dysplasia of the hip (DDH) Crowe type IV poses significant surgical challenges during total hip arthroplasty (THA), often necessitating subtrochanteric shortening osteotomy (SSO) to achieve proper reduction and limb length restoration. Stable fixation of the osteotomy site is crucial for achieving reliable union and favorable functional outcomes.</p><p><strong>Objective: </strong>To evaluate early clinical and radiographic outcomes of stable fixation using a derotational plate in subtrochanteric osteotomy for Crowe IV DDH.</p><p><strong>Methods: </strong>A prospective cohort study was conducted on 28 patients (30 hips) with Crowe IV DDH who underwent THA combined with subtrochanteric osteotomy stabilized by a derotational plate. Clinical evaluation included the Harris Hip Score (HHS), Oxford Hip Score (OHS), and Visual Analogue Scale (VAS) for pain, assessed preoperatively and at 12 months postoperatively. Radiographic analysis focused on osteotomy union, implant stability, and restoration of limb length.</p><p><strong>Results: </strong>All patients achieved union at the osteotomy site within 6 months, with no cases of nonunion or implant failure. Mean HHS improved from 38.5 ± 6.2 preoperatively to 89.7 ± 4.3 postoperatively (p < 0.001). Mean OHS increased from 17.4 ± 3.1 to 41.2 ± 2.8 (p < 0.001). VAS scores significantly decreased from 7.8 ± 1.0 to 1.6 ± 0.7 (p < 0.001). Complications were minimal, with one intraoperative femoral fissure (3.3%).</p><p><strong>Conclusion: </strong>Stable fixation with a derotational plate in subtrochanteric osteotomy for Crowe IV DDH provides reliable union, excellent early functional recovery, and significant pain reduction at 12 months. These findings support its clinical effectiveness as a fixation method in complex THA cases.</p>","PeriodicalId":19669,"journal":{"name":"Orthopedic Reviews","volume":"17 ","pages":"150316"},"PeriodicalIF":2.1,"publicationDate":"2025-12-22","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12727426/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145834426","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Radiofrequency Ablation and Cryoablation in Treating Painful Bone Metastasis: A Comprehensive Systematic Review and Separate Single-Arm Meta-analysis. 射频消融和冷冻消融治疗疼痛性骨转移:一项综合系统评价和单独的单臂荟萃分析。
IF 2.1 Q3 ORTHOPEDICS Pub Date : 2025-12-22 eCollection Date: 2025-01-01 DOI: 10.52965/001c.150315
Motaz Alaqeel, Abdullah Alnajres, Yara Mulia, Mishari Alanezi, Shaikhah Alsenani, Farah Alqazlan, Mohammad Aljarba, Waleed Albishi, Ibrahim Alshaygy, Abdulrahman Alaseem

Background and aim: Bone metastases cause pain and disability in advanced prostate, breast, and lung cancers. Traditional treatments may not work for all patients. Minimally invasive procedures such as cryoablation (CA) and radiofrequency ablation (RFA) have emerged as good options. This review aims to evaluate and summarize the effectiveness and safety of CA and RFA separately in managing painful bone metastases.

Methods: We performed a comprehensive search of Ovid Medline, Google Scholar, Web of Science, CENTRAL, and ClinicalTrials.gov covering studies published between January 2000 and January 2025. The search included English-language cohorts. or randomized trials of adults (≥18 years) with bone metastases treated using RFA or CA. Outcomes such as pain levels, tumor recurrence, and adverse events were collected from each study. To assess the quality and reliability of the studies, we used the Cochrane Risk of Bias 2 (RoB 2) tool for randomized trials and the ROBINS-I tool for nonrandomized studies. We performed separate single-arm meta-analyses for RFA and for CA and integrated findings from the small number of direct comparative studies using a narrative synthesis.We performed separate single-arm meta-analyses for RFA and for CA and integrated findings from the small number of direct comparative cohort studies using a narrative synthesis.

Results: A total of 30 studies involving 1121 patients were included in the qualitative synthesis, and 24 were included in the meta-analysis. Separate single-arm meta-analyses revealed that both radiofrequency ablation (RFA) and cryoablation (CA) significantly reduced pain at all follow-up timepoints. RFA had the greatest pain reduction at 6 months (SMD: -3.50; 95% CI: -4.42, -2.27), whereas CA had a greater effect at 24 hours (SMD: -2.43; 95% CI: -3.84, -1.02) but ,a smaller effect at 6 months (SMD: -2.14; 95% CI: -3.43, -0.85). Both were safe, with mostly mild adverse events. The reported tumor control outcomes have been inconsistent, limiting conclusions in this area.

Conclusion: On separate analyses, CA appeared to produce larger short-term effect sizes (greater early pain reduction) while RFA had larger medium/long-term effect sizes in the available studies. Because direct comparative data are sparse and heterogeneous, these observations do not establish superiority of one modality over the other. Both techniques demonstrated favorable safety profiles across included studies. Ablation combined with external beam radiation therapy (EBRT) was superior to either modality alone. Standardized measures and more comparative studies are needed to guide treatment.

背景和目的:骨转移在晚期前列腺癌、乳腺癌和肺癌中引起疼痛和残疾。传统疗法未必对所有患者都有效。微创手术如冷冻消融(CA)和射频消融(RFA)已成为不错的选择。本综述旨在评价和总结CA和RFA分别治疗疼痛性骨转移的有效性和安全性。方法:我们在Ovid Medline、谷歌Scholar、Web of Science、CENTRAL和ClinicalTrials.gov网站上进行了全面的搜索,涵盖2000年1月至2025年1月之间发表的研究。搜索包括英语队列。或使用RFA或CA治疗骨转移的成人(≥18岁)的随机试验。从每项研究中收集疼痛水平、肿瘤复发和不良事件等结果。为了评估研究的质量和可靠性,我们对随机试验使用Cochrane风险偏倚2 (RoB 2)工具,对非随机研究使用ROBINS-I工具。我们对RFA和CA进行了单独的单臂荟萃分析,并使用叙事综合方法整合了少量直接比较研究的结果。我们对RFA和CA进行了单独的单臂荟萃分析,并使用叙事综合方法整合了少量直接比较队列研究的结果。结果:共纳入30项研究,纳入1121例患者,纳入meta分析24例。单独的单臂荟萃分析显示,射频消融(RFA)和冷冻消融(CA)在所有随访时间点都能显著减轻疼痛。RFA在6个月时疼痛减轻最大(SMD: -3.50; 95% CI: -4.42, -2.27),而CA在24小时时效果更大(SMD: -2.43; 95% CI: -3.84, -1.02),但在6个月时效果较小(SMD: -2.14; 95% CI: -3.43, -0.85)。两者都是安全的,大多有轻微的不良事件。报道的肿瘤控制结果不一致,限制了这一领域的结论。结论:在单独的分析中,CA似乎产生更大的短期效应(更大的早期疼痛减轻),而RFA在现有研究中具有更大的中期/长期效应。由于直接比较数据是稀疏和异构的,这些观察结果并不能确定一种模式优于另一种模式。在纳入的研究中,这两种技术都显示出良好的安全性。消融联合外束放射治疗(EBRT)优于单独治疗。需要标准化的措施和更多的比较研究来指导治疗。
{"title":"Radiofrequency Ablation and Cryoablation in Treating Painful Bone Metastasis: A Comprehensive Systematic Review and Separate Single-Arm Meta-analysis.","authors":"Motaz Alaqeel, Abdullah Alnajres, Yara Mulia, Mishari Alanezi, Shaikhah Alsenani, Farah Alqazlan, Mohammad Aljarba, Waleed Albishi, Ibrahim Alshaygy, Abdulrahman Alaseem","doi":"10.52965/001c.150315","DOIUrl":"10.52965/001c.150315","url":null,"abstract":"<p><strong>Background and aim: </strong>Bone metastases cause pain and disability in advanced prostate, breast, and lung cancers. Traditional treatments may not work for all patients. Minimally invasive procedures such as cryoablation (CA) and radiofrequency ablation (RFA) have emerged as good options. This review aims to evaluate and summarize the effectiveness and safety of CA and RFA separately in managing painful bone metastases.</p><p><strong>Methods: </strong>We performed a comprehensive search of Ovid Medline, Google Scholar, Web of Science, CENTRAL, and ClinicalTrials.gov covering studies published between January 2000 and January 2025. The search included English-language cohorts. or randomized trials of adults (≥18 years) with bone metastases treated using RFA or CA. Outcomes such as pain levels, tumor recurrence, and adverse events were collected from each study. To assess the quality and reliability of the studies, we used the Cochrane Risk of Bias 2 (RoB 2) tool for randomized trials and the ROBINS-I tool for nonrandomized studies. We performed separate single-arm meta-analyses for RFA and for CA and integrated findings from the small number of direct comparative studies using a narrative synthesis.We performed separate single-arm meta-analyses for RFA and for CA and integrated findings from the small number of direct comparative cohort studies using a narrative synthesis.</p><p><strong>Results: </strong>A total of 30 studies involving 1121 patients were included in the qualitative synthesis, and 24 were included in the meta-analysis. Separate single-arm meta-analyses revealed that both radiofrequency ablation (RFA) and cryoablation (CA) significantly reduced pain at all follow-up timepoints. RFA had the greatest pain reduction at 6 months (SMD: -3.50; 95% CI: -4.42, -2.27), whereas CA had a greater effect at 24 hours (SMD: -2.43; 95% CI: -3.84, -1.02) but ,a smaller effect at 6 months (SMD: -2.14; 95% CI: -3.43, -0.85). Both were safe, with mostly mild adverse events. The reported tumor control outcomes have been inconsistent, limiting conclusions in this area.</p><p><strong>Conclusion: </strong>On separate analyses, CA appeared to produce larger short-term effect sizes (greater early pain reduction) while RFA had larger medium/long-term effect sizes in the available studies. Because direct comparative data are sparse and heterogeneous, these observations do not establish superiority of one modality over the other. Both techniques demonstrated favorable safety profiles across included studies. Ablation combined with external beam radiation therapy (EBRT) was superior to either modality alone. Standardized measures and more comparative studies are needed to guide treatment.</p>","PeriodicalId":19669,"journal":{"name":"Orthopedic Reviews","volume":"17 ","pages":"150315"},"PeriodicalIF":2.1,"publicationDate":"2025-12-22","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12727478/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145834459","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Innovative Anatomical Plate for Surgical Fixation of Acromial-End Clavicle Fractures: A Case Report. 创新解剖钢板治疗肩端锁骨骨折1例报告。
IF 2.1 Q3 ORTHOPEDICS Pub Date : 2025-12-22 eCollection Date: 2025-01-01 DOI: 10.52965/001c.150378
Nagmet Mursalov, Yerdar Shaukhin

Introduction: Distal clavicle fractures are uncommon and present clinical challenges due to complex anatomy and instability. Standard fixation plates often fail to match the clavicle's contour, requiring bending that may weaken fixation and cause irritation.

Case presentation: A 39-year-old male sustained a Neer type IIb distal clavicle fracture after a fall on the right shoulder. Clinical and radiographic evaluation revealed a comminuted fracture with pain and restricted motion. Management and Outcomes: Open reduction and internal fixation with a newly designed anatomical plate were performed under general anesthesia using seven locking screws. Rehabilitation began early, and recovery was uneventful. At two months, radiographs confirmed union and alignment, with full, pain-free motion and improved Constant and ASES scores.

Conclusion: The newly developed anatomical plate provided stable fixation and excellent functional recovery. Further studies with larger cohorts and longer follow-up are required to validate long-term efficacy.

锁骨远端骨折是罕见的,由于复杂的解剖结构和不稳定性,目前的临床挑战。标准的固定钢板往往不能匹配锁骨的轮廓,需要弯曲,这可能会削弱固定并引起刺激。病例介绍:一名39岁男性在右肩跌倒后,持续发生IIb型锁骨远端骨折。临床和影像学评估显示为粉碎性骨折,伴有疼痛和活动受限。处理和结果:在全麻下使用7枚锁定螺钉进行切开复位和新设计的解剖钢板内固定。康复工作很早就开始了,康复过程很顺利。2个月时,x线片证实骨愈合和对齐,运动充分、无痛,Constant和ASES评分提高。结论:新型解剖钢板固定稳定,功能恢复良好。进一步的研究需要更大的队列和更长时间的随访来验证长期疗效。
{"title":"Innovative Anatomical Plate for Surgical Fixation of Acromial-End Clavicle Fractures: A Case Report.","authors":"Nagmet Mursalov, Yerdar Shaukhin","doi":"10.52965/001c.150378","DOIUrl":"10.52965/001c.150378","url":null,"abstract":"<p><strong>Introduction: </strong>Distal clavicle fractures are uncommon and present clinical challenges due to complex anatomy and instability. Standard fixation plates often fail to match the clavicle's contour, requiring bending that may weaken fixation and cause irritation.</p><p><strong>Case presentation: </strong>A 39-year-old male sustained a Neer type IIb distal clavicle fracture after a fall on the right shoulder. Clinical and radiographic evaluation revealed a comminuted fracture with pain and restricted motion. Management and Outcomes: Open reduction and internal fixation with a newly designed anatomical plate were performed under general anesthesia using seven locking screws. Rehabilitation began early, and recovery was uneventful. At two months, radiographs confirmed union and alignment, with full, pain-free motion and improved Constant and ASES scores.</p><p><strong>Conclusion: </strong>The newly developed anatomical plate provided stable fixation and excellent functional recovery. Further studies with larger cohorts and longer follow-up are required to validate long-term efficacy.</p>","PeriodicalId":19669,"journal":{"name":"Orthopedic Reviews","volume":"17 ","pages":"150378"},"PeriodicalIF":2.1,"publicationDate":"2025-12-22","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12727430/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145834431","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Long-term outcomes of single-stage versus two-stage revision for prosthetic joint infection: a retrospective, observational cohort study. 假体关节感染单期翻修与两期翻修的长期结果:一项回顾性观察队列研究
IF 2.1 Q3 ORTHOPEDICS Pub Date : 2025-11-24 eCollection Date: 2025-01-01 DOI: 10.52965/001c.147165
Aishwarya Ghosh, Suroosh Madanipour, John Stammers, Philip Mitchell, Sulaiman Alazzawi

Background & objective: To compare long-term outcomes of single-stage and two-stage revision procedures for prosthetic joint infection (PJI) in total joint arthroplasty, with a focus on infection clearance and treatment failure rates in demographically similar patient cohorts. # Methods A retrospective cohort study was conducted at a tertiary referral centre between 2011 and 2021. Patients who underwent either single-stage or two-stage revision for PJI and completed a minimum of two years of follow-up were included. They were identified from electronic health records and hospital databases. Infection clearance at final follow-up was the primary outcome. Treatment failure was defined as need for further revision or long-term suppressive antibiotics.

Results: A total of 75 patients were included, with 50 undergoing single-stage revision and 25 undergoing two-stage revision. The groups were similar for age, joint type and MacPherson host grade. Mean follow-up was 4.2 years (range 2-9). Infection clearance was achieved in 48 patients (96%) in the single-stage group and 23 patients (92%) in the two-stage group (p = 0.624). Treatment failure occurred in two patients (4%) in the single-stage group and in two patients (8%) in the two-stage group. Patients in the single-stage group received significantly longer courses of post-operative antibiotics (mean 6.2 weeks vs 4.8 weeks; p= 0.0058). All-cause 5-year and 10-year mortality was similar between groups (p=0.85).

Conclusion: In patients with chronic PJI and similar demographic profiles, selected patients undergoing single-stage revision demonstrated comparable infection clearance and mortality compared with two-stage revision. These findings support the increasing use of single-stage revision in appropriately selected patients.

背景与目的:比较全关节置换术中假体关节感染(PJI)单期和两期翻修手术的长期结果,重点研究人口统计学相似患者队列的感染清除率和治疗失败率。方法2011年至2021年在一家三级转诊中心进行回顾性队列研究。接受PJI单期或两期翻修并完成至少两年随访的患者被纳入研究。他们是从电子健康记录和医院数据库中识别出来的。最终随访时感染清除是主要结局。治疗失败被定义为需要进一步翻修或长期抑制抗生素。结果:共纳入75例患者,其中50例进行单期翻修,25例进行两期翻修。各组在年龄、关节类型和MacPherson宿主分级上相似。平均随访4.2年(范围2-9年)。单期组48例(96%)感染清除率达到,两期组23例(92%)感染清除率达到(p = 0.624)。单期组中有2例(4%)患者治疗失败,两期组中有2例(8%)患者治疗失败。单期组患者术后抗生素疗程明显延长(平均6.2周vs 4.8周;p= 0.0058)。两组间全因5年和10年死亡率相似(p=0.85)。结论:在慢性PJI患者和类似的人口统计资料中,选择接受单阶段翻修的患者与两阶段翻修的患者相比,感染清除率和死亡率相当。这些发现支持在适当选择的患者中越来越多地使用单期翻修。
{"title":"Long-term outcomes of single-stage versus two-stage revision for prosthetic joint infection: a retrospective, observational cohort study.","authors":"Aishwarya Ghosh, Suroosh Madanipour, John Stammers, Philip Mitchell, Sulaiman Alazzawi","doi":"10.52965/001c.147165","DOIUrl":"https://doi.org/10.52965/001c.147165","url":null,"abstract":"<p><strong>Background & objective: </strong>To compare long-term outcomes of single-stage and two-stage revision procedures for prosthetic joint infection (PJI) in total joint arthroplasty, with a focus on infection clearance and treatment failure rates in demographically similar patient cohorts. # Methods A retrospective cohort study was conducted at a tertiary referral centre between 2011 and 2021. Patients who underwent either single-stage or two-stage revision for PJI and completed a minimum of two years of follow-up were included. They were identified from electronic health records and hospital databases. Infection clearance at final follow-up was the primary outcome. Treatment failure was defined as need for further revision or long-term suppressive antibiotics.</p><p><strong>Results: </strong>A total of 75 patients were included, with 50 undergoing single-stage revision and 25 undergoing two-stage revision. The groups were similar for age, joint type and MacPherson host grade. Mean follow-up was 4.2 years (range 2-9). Infection clearance was achieved in 48 patients (96%) in the single-stage group and 23 patients (92%) in the two-stage group (p = 0.624). Treatment failure occurred in two patients (4%) in the single-stage group and in two patients (8%) in the two-stage group. Patients in the single-stage group received significantly longer courses of post-operative antibiotics (mean 6.2 weeks vs 4.8 weeks; p= 0.0058). All-cause 5-year and 10-year mortality was similar between groups (p=0.85).</p><p><strong>Conclusion: </strong>In patients with chronic PJI and similar demographic profiles, selected patients undergoing single-stage revision demonstrated comparable infection clearance and mortality compared with two-stage revision. These findings support the increasing use of single-stage revision in appropriately selected patients.</p>","PeriodicalId":19669,"journal":{"name":"Orthopedic Reviews","volume":"17 ","pages":"147165"},"PeriodicalIF":2.1,"publicationDate":"2025-11-24","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12646819/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145637027","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Predictors of Pulmonary Complications Including Unplanned Intubation Within 30 Days of Femoral Open Reduction and Internal Fixation. 股骨切开复位和内固定术后30天内包括计划外插管在内的肺部并发症的预测因素。
IF 2.1 Q3 ORTHOPEDICS Pub Date : 2025-11-24 eCollection Date: 2025-01-01 DOI: 10.52965/001c.147166
Vikram Ganguli, Thor S Stead, Sofia Malik, Latha Ganti

Pulmonary complications, such as pneumonia, ventilator dependence, and unplanned intubation, can occur after femoral open reduction and internal fixation (ORIF). This study aimed to identify predictors of pulmonary complications including unplanned intubation within 30 days of femoral open reduction and internal fixation, using the large NSQIP surgical database. # Methods This study used the American College of Surgeons National Surgical Quality Improvement Program (NSQIP) database, which is a de-identified registry that includes the surgical data from over 700 hospitals each year. The NSQIP database was queried for patients undergoing femoral open reduction and internal fixation. Multivariate logistic analysis models identified predictors for postoperative pneumonia, ventilator dependence >48 hours, and unplanned intubation. Predictors examined included demographics, comorbidities (COPD, CHF, renal failure), anesthesia type, ASA classification, and smoking status. Statistical significance was set at p<0.05. # Results Significant independent predictors were found for all 3 pulmonary complications analysed for. Significant independent predictors for postoperative pneumonia included male sex (p<0.0001), COPD (p<0.0001), CHF (p=0.0015), renal failure (p<0.0001), higher ASA class (p<0.0001), and current smoking (p=0.0099). For ventilator dependence >48 hours, significant predictors were COPD (p<0.0001), CHF (p=0.0067), renal failure (p<0.0001), higher ASA class (p<0.0001), smoking (p<0.0001), and epidural or spinal anesthesia compared to general anesthesia (p=0.0017). For unplanned intubation, COPD (p<0.0001), CHF (p=0.0015), renal failure (p<0.0001), and higher ASA class (p<0.0001) were significant predictors. # Conclusion In this database, higher ASA class, COPD, CHF, renal failure, male sex, and smoking were independently associated with increased risk of pulmonary complications after femoral ORIF. This information can help surgeons further understand the pulmonary risks in this procedure, watch high risk patients closer, and help patients lower their risks of pulmonary complications through lifestyle changes, regarding variables like smoking, and drug interventions.

股骨切开复位内固定(ORIF)后可发生肺部并发症,如肺炎、呼吸机依赖和计划外插管。本研究旨在利用大型NSQIP手术数据库,确定包括股骨切开复位和内固定术后30天内计划外插管在内的肺部并发症的预测因素。本研究使用了美国外科医师学会国家手术质量改进计划(NSQIP)数据库,该数据库是一个去识别的注册表,包括每年700多家医院的手术数据。在NSQIP数据库中查询股骨切开复位内固定的患者。多变量logistic分析模型确定了术后肺炎、呼吸机依赖bbb48小时和计划外插管的预测因素。预测因素包括人口统计学、合并症(COPD、CHF、肾衰竭)、麻醉类型、ASA分类和吸烟状况。在p48小时有统计学意义,COPD (p
{"title":"Predictors of Pulmonary Complications Including Unplanned Intubation Within 30 Days of Femoral Open Reduction and Internal Fixation.","authors":"Vikram Ganguli, Thor S Stead, Sofia Malik, Latha Ganti","doi":"10.52965/001c.147166","DOIUrl":"https://doi.org/10.52965/001c.147166","url":null,"abstract":"<p><p>Pulmonary complications, such as pneumonia, ventilator dependence, and unplanned intubation, can occur after femoral open reduction and internal fixation (ORIF). This study aimed to identify predictors of pulmonary complications including unplanned intubation within 30 days of femoral open reduction and internal fixation, using the large NSQIP surgical database. # Methods This study used the American College of Surgeons National Surgical Quality Improvement Program (NSQIP) database, which is a de-identified registry that includes the surgical data from over 700 hospitals each year. The NSQIP database was queried for patients undergoing femoral open reduction and internal fixation. Multivariate logistic analysis models identified predictors for postoperative pneumonia, ventilator dependence >48 hours, and unplanned intubation. Predictors examined included demographics, comorbidities (COPD, CHF, renal failure), anesthesia type, ASA classification, and smoking status. Statistical significance was set at p<0.05. # Results Significant independent predictors were found for all 3 pulmonary complications analysed for. Significant independent predictors for postoperative pneumonia included male sex (p<0.0001), COPD (p<0.0001), CHF (p=0.0015), renal failure (p<0.0001), higher ASA class (p<0.0001), and current smoking (p=0.0099). For ventilator dependence >48 hours, significant predictors were COPD (p<0.0001), CHF (p=0.0067), renal failure (p<0.0001), higher ASA class (p<0.0001), smoking (p<0.0001), and epidural or spinal anesthesia compared to general anesthesia (p=0.0017). For unplanned intubation, COPD (p<0.0001), CHF (p=0.0015), renal failure (p<0.0001), and higher ASA class (p<0.0001) were significant predictors. # Conclusion In this database, higher ASA class, COPD, CHF, renal failure, male sex, and smoking were independently associated with increased risk of pulmonary complications after femoral ORIF. This information can help surgeons further understand the pulmonary risks in this procedure, watch high risk patients closer, and help patients lower their risks of pulmonary complications through lifestyle changes, regarding variables like smoking, and drug interventions.</p>","PeriodicalId":19669,"journal":{"name":"Orthopedic Reviews","volume":"17 ","pages":"147166"},"PeriodicalIF":2.1,"publicationDate":"2025-11-24","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12646820/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145637066","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Primary Cardiac Osteosarcoma: Epidemiology, Diagnosis, and Management - A Narrative Review. 原发性心脏骨肉瘤:流行病学、诊断和治疗综述。
IF 2.1 Q3 ORTHOPEDICS Pub Date : 2025-11-24 eCollection Date: 2025-01-01 DOI: 10.52965/001c.147169
Tommy Li, Eric Nguyen, Jamal Hasoon, Ali Khalifa, Anvinh Nguyen

Primary cardiac sarcomas are exceedingly rare, with a very low incidence in the general population. A variety of sarcoma subtypes can originate in the heart, including angiosarcoma, rhabdomyosarcoma, leiomyosarcoma, fibrosarcoma, and osteosarcoma. These tumors are typically classified based on histological characteristics, most often determined following surgical excision or biopsy. Among them, primary cardiac osteosarcoma is one of the rarest forms, with fewer than 60 cases reported in the literature to date. This narrative review aims to provide an overview of primary cardiac osteosarcoma, including its epidemiology, clinical presentation, and current management strategies. Additionally, we highlight several remarkable case reports to illustrate the variability and complexity of this rare malignancy. # Summary The clinical presentation of primary cardiac osteosarcoma often mimics other cardiac conditions such as heart failure, mitral stenosis, or coronary artery disease, making diagnosis challenging. Transthoracic echocardiography (TTE) is typically the first imaging modality to detect a cardiac mass. Due to the rarity of the tumor, established treatment protocols are limited. Surgical resection is generally the preferred initial approach for localized disease without metastasis. Chemotherapy and radiation therapy may also be used, but their application must be carefully considered given the heart's sensitivity to these treatments. Despite advances in imaging, surgical techniques, and adjuvant therapies that have improved survival in some cases, the overall prognosis for primary cardiac osteosarcoma remains poor. # Conclusion Because primary cardiac osteosarcoma is so rare, establishing standardized treatment guidelines remains challenging. By reviewing historical cases and examining current clinical management strategies, we aim to contribute to a better understanding of this aggressive malignancy and ultimately improve patient outcomes.

原发性心脏肉瘤极为罕见,在一般人群中发病率极低。多种肉瘤亚型可起源于心脏,包括血管肉瘤、横纹肌肉瘤、平滑肌肉瘤、纤维肉瘤和骨肉瘤。这些肿瘤通常根据组织学特征进行分类,最常在手术切除或活检后确定。其中,原发性心脏骨肉瘤是最罕见的形式之一,迄今文献报道的病例不足60例。本文旨在对原发性心脏骨肉瘤进行综述,包括其流行病学、临床表现和当前的治疗策略。此外,我们强调几个显著的病例报告,以说明这种罕见的恶性肿瘤的变异性和复杂性。原发性心脏骨肉瘤的临床表现通常类似于其他心脏疾病,如心力衰竭、二尖瓣狭窄或冠状动脉疾病,这使得诊断具有挑战性。经胸超声心动图(TTE)通常是检测心脏肿块的第一种成像方式。由于肿瘤的罕见性,现有的治疗方案是有限的。对于没有转移的局部疾病,手术切除通常是首选的初始方法。化疗和放射治疗也可以使用,但考虑到心脏对这些治疗的敏感性,它们的应用必须仔细考虑。尽管影像学、手术技术和辅助治疗的进步提高了一些病例的生存率,但原发性心脏骨肉瘤的总体预后仍然很差。由于原发性心脏骨肉瘤非常罕见,建立标准化的治疗指南仍然具有挑战性。通过回顾历史病例和检查当前的临床管理策略,我们的目标是有助于更好地了解这种侵袭性恶性肿瘤,并最终改善患者的预后。
{"title":"Primary Cardiac Osteosarcoma: Epidemiology, Diagnosis, and Management - A Narrative Review.","authors":"Tommy Li, Eric Nguyen, Jamal Hasoon, Ali Khalifa, Anvinh Nguyen","doi":"10.52965/001c.147169","DOIUrl":"https://doi.org/10.52965/001c.147169","url":null,"abstract":"<p><p>Primary cardiac sarcomas are exceedingly rare, with a very low incidence in the general population. A variety of sarcoma subtypes can originate in the heart, including angiosarcoma, rhabdomyosarcoma, leiomyosarcoma, fibrosarcoma, and osteosarcoma. These tumors are typically classified based on histological characteristics, most often determined following surgical excision or biopsy. Among them, primary cardiac osteosarcoma is one of the rarest forms, with fewer than 60 cases reported in the literature to date. This narrative review aims to provide an overview of primary cardiac osteosarcoma, including its epidemiology, clinical presentation, and current management strategies. Additionally, we highlight several remarkable case reports to illustrate the variability and complexity of this rare malignancy. # Summary The clinical presentation of primary cardiac osteosarcoma often mimics other cardiac conditions such as heart failure, mitral stenosis, or coronary artery disease, making diagnosis challenging. Transthoracic echocardiography (TTE) is typically the first imaging modality to detect a cardiac mass. Due to the rarity of the tumor, established treatment protocols are limited. Surgical resection is generally the preferred initial approach for localized disease without metastasis. Chemotherapy and radiation therapy may also be used, but their application must be carefully considered given the heart's sensitivity to these treatments. Despite advances in imaging, surgical techniques, and adjuvant therapies that have improved survival in some cases, the overall prognosis for primary cardiac osteosarcoma remains poor. # Conclusion Because primary cardiac osteosarcoma is so rare, establishing standardized treatment guidelines remains challenging. By reviewing historical cases and examining current clinical management strategies, we aim to contribute to a better understanding of this aggressive malignancy and ultimately improve patient outcomes.</p>","PeriodicalId":19669,"journal":{"name":"Orthopedic Reviews","volume":"17 ","pages":"147169"},"PeriodicalIF":2.1,"publicationDate":"2025-11-24","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12646821/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145637179","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Platelet-Rich Plasma Therapy in Treating Tendon Injuries of the Hand: A Narrative Review. 富血小板血浆疗法治疗手部肌腱损伤:叙述性回顾。
IF 2.1 Q3 ORTHOPEDICS Pub Date : 2025-11-24 eCollection Date: 2025-01-01 DOI: 10.52965/001c.147173
Rita Saad, Wendy Ghanem, Hady Ezzeddine, Fouad Assaf, Elyssa Kiwan, Omar Al Fakih, Mohamad Badra, Ramzi Moucharafieh

Platelet-rich plasma (PRP) therapy has emerged as a biologically based approach to enhance tendon healing and functional recovery in hand and other musculoskeletal injuries. PRP is an autologous concentrate of platelets and growth factors, including platelet-derived growth factor (PDGF), transforming growth factor-beta (TGF-β), insulin-like growth factor (IGF), and vascular endothelial growth factor (VEGF), which modulate inflammation, stimulate tenocyte proliferation, promote collagen synthesis, and support angiogenesis. Preclinical studies demonstrate that PRP improves extracellular matrix remodeling, collagen fiber alignment, and biomechanical strength in injured tendons, with effects influenced by PRP formulation, leukocyte content, activation method, and timing of application. Clinical evidence in hand tendon injuries-particularly flexor tendon repair, chronic tendinopathies, and stenosing tenosynovitis-suggests that PRP is generally safe and may enhance tendon morphology, range of motion, pain relief, and return to function. However, results are heterogeneous, with some randomized trials showing limited short-term functional improvements compared to conventional treatments such as corticosteroids, hyaluronic acid, or percutaneous needle tenotomy. The variability in outcomes reflects differences in PRP preparation, injection protocols, injury chronicity, and study design. Beyond the hand, PRP has been applied to rotator cuff, lateral epicondylitis, plantar fasciitis, ligament injuries, and spinal surgery, with mixed results and some evidence of tissue-specific limitations. Current challenges include standardizing PRP formulations, optimizing dosing and delivery, and identifying patient- and injury-specific factors influencing response. Future research should prioritize multicenter, well-powered randomized trials with uniform outcome measures, long-term follow-up, robust safety monitoring, and exploration of combination therapies to clarify the therapeutic role of PRP and support evidence-based integration into clinical practice.

富血小板血浆(PRP)治疗已成为一种基于生物学的方法,可促进手部和其他肌肉骨骼损伤的肌腱愈合和功能恢复。PRP是血小板和生长因子的自体浓缩物,包括血小板源性生长因子(PDGF)、转化生长因子-β (TGF-β)、胰岛素样生长因子(IGF)和血管内皮生长因子(VEGF),它们调节炎症、刺激细胞增殖、促进胶原合成和支持血管生成。临床前研究表明,PRP可改善损伤肌腱的细胞外基质重塑、胶原纤维排列和生物力学强度,其作用受PRP配方、白细胞含量、激活方法和应用时间的影响。手部肌腱损伤的临床证据-特别是屈肌腱修复,慢性肌腱病和狭窄性腱鞘炎-表明PRP通常是安全的,并且可以增强肌腱形态,运动范围,疼痛缓解和恢复功能。然而,结果是不均匀的,一些随机试验显示,与常规治疗(如皮质类固醇、透明质酸或经皮针刺肌腱切开术)相比,短期功能改善有限。结果的可变性反映了PRP制备、注射方案、损伤慢性性和研究设计的差异。除手部外,PRP已应用于肩袖、外侧上髁炎、足底筋膜炎、韧带损伤和脊柱手术,结果不一,并有一些组织特异性局限性的证据。目前的挑战包括标准化PRP配方,优化剂量和递送,以及确定影响反应的患者和损伤特异性因素。未来的研究应优先考虑多中心、有力的随机试验、统一的结果测量、长期随访、可靠的安全性监测和探索联合疗法,以阐明PRP的治疗作用,并支持循证整合到临床实践中。
{"title":"Platelet-Rich Plasma Therapy in Treating Tendon Injuries of the Hand: A Narrative Review.","authors":"Rita Saad, Wendy Ghanem, Hady Ezzeddine, Fouad Assaf, Elyssa Kiwan, Omar Al Fakih, Mohamad Badra, Ramzi Moucharafieh","doi":"10.52965/001c.147173","DOIUrl":"https://doi.org/10.52965/001c.147173","url":null,"abstract":"<p><p>Platelet-rich plasma (PRP) therapy has emerged as a biologically based approach to enhance tendon healing and functional recovery in hand and other musculoskeletal injuries. PRP is an autologous concentrate of platelets and growth factors, including platelet-derived growth factor (PDGF), transforming growth factor-beta (TGF-β), insulin-like growth factor (IGF), and vascular endothelial growth factor (VEGF), which modulate inflammation, stimulate tenocyte proliferation, promote collagen synthesis, and support angiogenesis. Preclinical studies demonstrate that PRP improves extracellular matrix remodeling, collagen fiber alignment, and biomechanical strength in injured tendons, with effects influenced by PRP formulation, leukocyte content, activation method, and timing of application. Clinical evidence in hand tendon injuries-particularly flexor tendon repair, chronic tendinopathies, and stenosing tenosynovitis-suggests that PRP is generally safe and may enhance tendon morphology, range of motion, pain relief, and return to function. However, results are heterogeneous, with some randomized trials showing limited short-term functional improvements compared to conventional treatments such as corticosteroids, hyaluronic acid, or percutaneous needle tenotomy. The variability in outcomes reflects differences in PRP preparation, injection protocols, injury chronicity, and study design. Beyond the hand, PRP has been applied to rotator cuff, lateral epicondylitis, plantar fasciitis, ligament injuries, and spinal surgery, with mixed results and some evidence of tissue-specific limitations. Current challenges include standardizing PRP formulations, optimizing dosing and delivery, and identifying patient- and injury-specific factors influencing response. Future research should prioritize multicenter, well-powered randomized trials with uniform outcome measures, long-term follow-up, robust safety monitoring, and exploration of combination therapies to clarify the therapeutic role of PRP and support evidence-based integration into clinical practice.</p>","PeriodicalId":19669,"journal":{"name":"Orthopedic Reviews","volume":"17 ","pages":"147173"},"PeriodicalIF":2.1,"publicationDate":"2025-11-24","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12646818/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145637086","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
A systematic review of objective return to sport criteria following hip arthroscopy for athletes. 对运动员髋关节镜检查后客观恢复运动标准的系统回顾。
IF 2.1 Q3 ORTHOPEDICS Pub Date : 2025-11-24 eCollection Date: 2025-01-01 DOI: 10.52965/001c.144729
Parker Scott, Cullen J Hegarty, Andrew Johnson, Joe Eischen, Aaron J Krych, Christopher Nagelli, Mario Hevesi

Purpose: Hip arthroscopy is a minimally invasive procedure which has been increasingly used among athletes for several hip joint related pathologies as it allows for a faster recovery. However, objective return to sport criteria have not been described previously among this population.

Objective: To systematically review the literature to evaluate and describe the objective return-to-sport (RTS) criteria to release patients back to sport following hip arthroscopy.

Methods: We conducted a comprehensive literature search according to the PRISMA guidelines. Studies were included in the review if patients underwent a hip arthroscopy procedure and the study described criteria for their patients to RTS. Two independent reviewers selected studies for inclusion and extracted study characteristics and objective RTS criteria.

Results: Of the 306 that were a part of our original search, 6 studies fit our inclusion criteria. There were 250 athletes (average age: 26.1) and 263 hips which underwent hip arthroscopy surgery. Of these athletes, the cohort was on average 46.5% female and an average of 91.2% of athletes returned to sport about 6 months following surgery. The primary sports these athletes participated in were soccer, swimming, skiing/snowboarding, and hockey. The objective RTS measures that were generally described included sport specific tests, range-of-motion, hip strength, and performance-based criteria.

Conclusion: There are minimal studies who described objective RTS criteria to release patients back to sport following hip arthroscopy procedures. Sports specific tests, hip strength, and performance-based criteria were mentioned as objective criteria to release patients back to sport.

目的:髋关节镜检查是一种微创手术,在运动员中越来越多地用于髋关节相关疾病,因为它允许更快的恢复。然而,在这一人群中,客观恢复到运动标准的情况以前没有描述过。目的:系统地回顾文献,评价和描述髋关节镜术后患者恢复运动的客观恢复运动(RTS)标准。方法:我们根据PRISMA指南进行了全面的文献检索。如果患者接受髋关节镜手术,研究被纳入综述,研究描述了患者进行RTS的标准。两名独立审稿人选择研究纳入并提取研究特征和客观RTS标准。结果:在我们原始检索的306项研究中,有6项研究符合我们的纳入标准。共有250名运动员(平均年龄26.1岁)和263个髋关节接受了髋关节镜手术。在这些运动员中,女性平均占46.5%,平均91.2%的运动员在手术后约6个月恢复运动。这些运动员参加的主要运动是足球、游泳、滑雪/单板滑雪和曲棍球。一般描述的客观RTS测量包括运动特定测试、活动范围、髋关节力量和基于表现的标准。结论:很少有研究描述了客观的RTS标准,以便在髋关节镜手术后让患者恢复运动。运动专项测试、髋关节力量和基于表现的标准被认为是让患者恢复运动的客观标准。
{"title":"A systematic review of objective return to sport criteria following hip arthroscopy for athletes.","authors":"Parker Scott, Cullen J Hegarty, Andrew Johnson, Joe Eischen, Aaron J Krych, Christopher Nagelli, Mario Hevesi","doi":"10.52965/001c.144729","DOIUrl":"https://doi.org/10.52965/001c.144729","url":null,"abstract":"<p><strong>Purpose: </strong>Hip arthroscopy is a minimally invasive procedure which has been increasingly used among athletes for several hip joint related pathologies as it allows for a faster recovery. However, objective return to sport criteria have not been described previously among this population.</p><p><strong>Objective: </strong>To systematically review the literature to evaluate and describe the objective return-to-sport (RTS) criteria to release patients back to sport following hip arthroscopy.</p><p><strong>Methods: </strong>We conducted a comprehensive literature search according to the PRISMA guidelines. Studies were included in the review if patients underwent a hip arthroscopy procedure and the study described criteria for their patients to RTS. Two independent reviewers selected studies for inclusion and extracted study characteristics and objective RTS criteria.</p><p><strong>Results: </strong>Of the 306 that were a part of our original search, 6 studies fit our inclusion criteria. There were 250 athletes (average age: 26.1) and 263 hips which underwent hip arthroscopy surgery. Of these athletes, the cohort was on average 46.5% female and an average of 91.2% of athletes returned to sport about 6 months following surgery. The primary sports these athletes participated in were soccer, swimming, skiing/snowboarding, and hockey. The objective RTS measures that were generally described included sport specific tests, range-of-motion, hip strength, and performance-based criteria.</p><p><strong>Conclusion: </strong>There are minimal studies who described objective RTS criteria to release patients back to sport following hip arthroscopy procedures. Sports specific tests, hip strength, and performance-based criteria were mentioned as objective criteria to release patients back to sport.</p>","PeriodicalId":19669,"journal":{"name":"Orthopedic Reviews","volume":"17 ","pages":"144729"},"PeriodicalIF":2.1,"publicationDate":"2025-11-24","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12646822/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145637001","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Time, Tumor, and Thrombosis: Drivers of 30-Day VTE After Femoral Fracture Surgery. 时间、肿瘤和血栓形成:股骨骨折术后30天静脉血栓栓塞的驱动因素。
IF 2.1 Q3 ORTHOPEDICS Pub Date : 2025-11-12 eCollection Date: 2025-01-01 DOI: 10.52965/001c.145867
Mona Satishkumar, Thor S Stead, Anjali K Banerjee, Latha Ganti

Background: Venous thromboembolism (VTE) remains a major source of morbidity after femoral fracture repair. We evaluated perioperative risk factors for 30-day deep vein thrombosis (DVT) and pulmonary embolism (PE) using a national clinical registry.

Methods: We conducted a retrospective cohort study of adults undergoing femoral fracture repair in the American College of Surgeons National Surgical Quality Improvement Program. Outcomes were 30-day DVT and PE. Candidate predictors included demographics, comorbidities, functional status, preoperative laboratory values, American Society of Anesthesiologists (ASA) class, and operative time. Multivariable logistic regression models were fit separately for DVT and PE. Model performance was assessed with area under the receiver operating characteristic curve (AUC).

Results: Disseminated cancer and longer operative time were independent predictors of postoperative DVT. Disseminated cancer conferred higher odds of DVT (adjusted odds ratio [aOR] 1.65, 95% CI 1.15-2.36, p=0.0065), and each additional operative minute increased DVT odds by 0.32% (aOR 1.0032, 95% CI 1.0017-1.0047, p<0.001), approximating 19% higher odds per 60 minutes. Body mass index (BMI) showed a borderline association (aOR 1.014 per kg/m², 95% CI 0.999-1.027, p=0.056), while age, sex, diabetes, smoking, functional status, preoperative creatinine, platelets, dialysis, heart failure, and preoperative INR were not significant. The DVT model demonstrated modest discrimination (AUC 0.57).For PE, disseminated cancer (aOR 2.77, 95% CI 1.92-4.00, p<0.001), longer operative time (aOR 1.0025 per minute, 95% CI 1.0006-1.0044, p=0.012), and higher BMI (aOR 1.018 per kg/m², 95% CI 1.002-1.035, p=0.031) were independent risk factors, whereas higher preoperative INR was protective (aOR 0.43 per unit, 95% CI 0.23-0.80, p=0.008). The PE model AUC was 0.61.

Conclusions: Within 30 days of femoral fracture repair, disseminated cancer and prolonged operative time consistently increased VTE risk; BMI contributed modestly, and higher preoperative INR reduced PE risk. These findings support targeted prophylaxis and heightened surveillance in high-risk subgroups and highlight the need for enhanced, multifactorial prediction tools.

背景:静脉血栓栓塞(VTE)仍然是股骨骨折修复后发病率的主要来源。我们使用国家临床登记来评估30天深静脉血栓形成(DVT)和肺栓塞(PE)的围手术期危险因素。方法:我们对美国外科医师学会国家手术质量改进计划中接受股骨骨折修复的成人进行了回顾性队列研究。结果为30天DVT和PE。候选预测因素包括人口统计学、合并症、功能状态、术前实验室值、美国麻醉医师学会(ASA)等级和手术时间。DVT和PE分别采用多变量logistic回归模型拟合。用受试者工作特征曲线下面积(AUC)评价模型性能。结果:播散性肿瘤和较长的手术时间是术后DVT的独立预测因素。弥散性癌症增加了发生DVT的几率(校正优势比[aOR] 1.65, 95% CI 1.15-2.36, p=0.0065),每增加一分钟手术时间,DVT的几率增加0.32% (aOR 1.0032, 95% CI 1.0017-1.0047, p)。结论:股骨骨折修复后30天内,弥散性癌症和延长的手术时间持续增加VTE的风险;BMI贡献较小,术前较高的INR降低了PE的风险。这些发现支持有针对性的预防和加强对高危亚群的监测,并强调需要改进多因素预测工具。
{"title":"Time, Tumor, and Thrombosis: Drivers of 30-Day VTE After Femoral Fracture Surgery.","authors":"Mona Satishkumar, Thor S Stead, Anjali K Banerjee, Latha Ganti","doi":"10.52965/001c.145867","DOIUrl":"10.52965/001c.145867","url":null,"abstract":"<p><strong>Background: </strong>Venous thromboembolism (VTE) remains a major source of morbidity after femoral fracture repair. We evaluated perioperative risk factors for 30-day deep vein thrombosis (DVT) and pulmonary embolism (PE) using a national clinical registry.</p><p><strong>Methods: </strong>We conducted a retrospective cohort study of adults undergoing femoral fracture repair in the American College of Surgeons National Surgical Quality Improvement Program. Outcomes were 30-day DVT and PE. Candidate predictors included demographics, comorbidities, functional status, preoperative laboratory values, American Society of Anesthesiologists (ASA) class, and operative time. Multivariable logistic regression models were fit separately for DVT and PE. Model performance was assessed with area under the receiver operating characteristic curve (AUC).</p><p><strong>Results: </strong>Disseminated cancer and longer operative time were independent predictors of postoperative DVT. Disseminated cancer conferred higher odds of DVT (adjusted odds ratio [aOR] 1.65, 95% CI 1.15-2.36, p=0.0065), and each additional operative minute increased DVT odds by 0.32% (aOR 1.0032, 95% CI 1.0017-1.0047, p<0.001), approximating 19% higher odds per 60 minutes. Body mass index (BMI) showed a borderline association (aOR 1.014 per kg/m², 95% CI 0.999-1.027, p=0.056), while age, sex, diabetes, smoking, functional status, preoperative creatinine, platelets, dialysis, heart failure, and preoperative INR were not significant. The DVT model demonstrated modest discrimination (AUC 0.57).For PE, disseminated cancer (aOR 2.77, 95% CI 1.92-4.00, p<0.001), longer operative time (aOR 1.0025 per minute, 95% CI 1.0006-1.0044, p=0.012), and higher BMI (aOR 1.018 per kg/m², 95% CI 1.002-1.035, p=0.031) were independent risk factors, whereas higher preoperative INR was protective (aOR 0.43 per unit, 95% CI 0.23-0.80, p=0.008). The PE model AUC was 0.61.</p><p><strong>Conclusions: </strong>Within 30 days of femoral fracture repair, disseminated cancer and prolonged operative time consistently increased VTE risk; BMI contributed modestly, and higher preoperative INR reduced PE risk. These findings support targeted prophylaxis and heightened surveillance in high-risk subgroups and highlight the need for enhanced, multifactorial prediction tools.</p>","PeriodicalId":19669,"journal":{"name":"Orthopedic Reviews","volume":"17 ","pages":"145867"},"PeriodicalIF":2.1,"publicationDate":"2025-11-12","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12615140/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145541901","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Identifying High-Risk Patients for Postoperative Renal Complications Following Femoral Intramedullary Fixation: A NSQIP Study. 鉴别股骨髓内固定术后肾并发症高危患者:一项NSQIP研究。
IF 2.1 Q3 ORTHOPEDICS Pub Date : 2025-11-12 eCollection Date: 2025-01-01 DOI: 10.52965/001c.145869
Sophia J Salazar, Thor S Stead, Eric G Yang, Latha Ganti

Background: Femoral intramedullary screw fixation is widely performed to stabilize femoral fractures. Although uncommon, postoperative acute kidney injury (AKI) and dialysis are serious complications associated with increased morbidity and mortality. This study aimed to identify predictors of AKI and postoperative dialysis following femoral intramedullary screw fixation.

Methods: We utilized the American College of Surgeons National Surgical Quality Improvement Program (NSQIP) database to identify patients undergoing femoral intramedullary screw fixation (CPT 27506) between 2018 and 2022. Predictors examined included demographic variables, comorbidities, preoperative laboratory values, ASA class, operative duration, and anesthesia type. Univariate analyses were performed, followed by multivariate logistic regression to determine independent risk factors for AKI and postoperative dialysis. Statistical significance was set at α = 0.05.

Results: A total of 63,734 patients were analyzed. Univariate predictors of AKI and postoperative dialysis included renal failure, elevated blood urea nitrogen, general anesthesia, hypertension, male sex, advanced age, decreased hematocrit, higher ASA class, diabetes, elevated BMI, and longer operative time. Multivariate logistic regression identified the following independent predictors: pre-existing renal insufficiency (p < 0.0001), elevated blood urea nitrogen (p < 0.0001), use of general anesthesia (p < 0.001), hypertension (p < 0.0001), male sex (p < 0.0001), older age (p < 0.001), decreased hematocrit (p < 0.001), ASA class III and IV (p = 0.0013, p = 0.0229), diabetes (p = 0.0038), and increased BMI (p = 0.0043).

Conclusion: This study identifies significant independent predictors of AKI and postoperative dialysis in patients undergoing femoral intramedullary screw fixation. Preoperative risk stratification incorporating these factors may improve perioperative planning and reduce adverse renal outcomes.

背景:股骨髓内螺钉固定被广泛应用于稳定股骨骨折。虽然不常见,但术后急性肾损伤(AKI)和透析是与发病率和死亡率增加相关的严重并发症。本研究旨在确定股骨髓内螺钉固定后AKI和术后透析的预测因素。方法:我们利用美国外科医师学会国家手术质量改进计划(NSQIP)数据库来识别2018年至2022年间接受股骨髓内螺钉固定(CPT 27506)的患者。预测因素包括人口统计学变量、合并症、术前实验室值、ASA分级、手术时间和麻醉类型。进行单因素分析,然后进行多因素logistic回归,以确定AKI和术后透析的独立危险因素。统计学意义设为α = 0.05。结果:共分析63734例患者。AKI和术后透析的单因素预测因素包括肾功能衰竭、尿素氮升高、全身麻醉、高血压、男性、高龄、血细胞比容下降、ASA等级升高、糖尿病、BMI升高和手术时间延长。多因素logistic回归确定了以下独立预测因素:既往存在肾功能不全(p < 0.0001)、血尿素氮升高(p < 0.0001)、全身麻醉(p < 0.001)、高血压(p < 0.0001)、男性(p < 0.0001)、年龄较大(p < 0.001)、血细胞比容降低(p < 0.001)、ASA III级和IV级(p = 0.0013, p = 0.0229)、糖尿病(p = 0.0038)和BMI升高(p = 0.0043)。结论:本研究确定了股骨髓内螺钉固定患者AKI和术后透析的重要独立预测因素。纳入这些因素的术前风险分层可以改善围手术期计划并减少肾脏不良后果。
{"title":"Identifying High-Risk Patients for Postoperative Renal Complications Following Femoral Intramedullary Fixation: A NSQIP Study.","authors":"Sophia J Salazar, Thor S Stead, Eric G Yang, Latha Ganti","doi":"10.52965/001c.145869","DOIUrl":"10.52965/001c.145869","url":null,"abstract":"<p><strong>Background: </strong>Femoral intramedullary screw fixation is widely performed to stabilize femoral fractures. Although uncommon, postoperative acute kidney injury (AKI) and dialysis are serious complications associated with increased morbidity and mortality. This study aimed to identify predictors of AKI and postoperative dialysis following femoral intramedullary screw fixation.</p><p><strong>Methods: </strong>We utilized the American College of Surgeons National Surgical Quality Improvement Program (NSQIP) database to identify patients undergoing femoral intramedullary screw fixation (CPT 27506) between 2018 and 2022. Predictors examined included demographic variables, comorbidities, preoperative laboratory values, ASA class, operative duration, and anesthesia type. Univariate analyses were performed, followed by multivariate logistic regression to determine independent risk factors for AKI and postoperative dialysis. Statistical significance was set at α = 0.05.</p><p><strong>Results: </strong>A total of 63,734 patients were analyzed. Univariate predictors of AKI and postoperative dialysis included renal failure, elevated blood urea nitrogen, general anesthesia, hypertension, male sex, advanced age, decreased hematocrit, higher ASA class, diabetes, elevated BMI, and longer operative time. Multivariate logistic regression identified the following independent predictors: pre-existing renal insufficiency (p < 0.0001), elevated blood urea nitrogen (p < 0.0001), use of general anesthesia (p < 0.001), hypertension (p < 0.0001), male sex (p < 0.0001), older age (p < 0.001), decreased hematocrit (p < 0.001), ASA class III and IV (p = 0.0013, p = 0.0229), diabetes (p = 0.0038), and increased BMI (p = 0.0043).</p><p><strong>Conclusion: </strong>This study identifies significant independent predictors of AKI and postoperative dialysis in patients undergoing femoral intramedullary screw fixation. Preoperative risk stratification incorporating these factors may improve perioperative planning and reduce adverse renal outcomes.</p>","PeriodicalId":19669,"journal":{"name":"Orthopedic Reviews","volume":"17 ","pages":"145869"},"PeriodicalIF":2.1,"publicationDate":"2025-11-12","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12615139/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145541875","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
Orthopedic Reviews
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1